Lipid storage |
Top2
|
none |
0.219352581 |
|
19067489
|
Lipid storage |
Top2
|
none |
0.010175199 |
|
19067489
|
ERK signaling |
Top2
|
ERK activation increased |
weak |
|
17086199
|
Alternative splicing |
Top2
|
none |
sp |
|
15492211
|
Cell size and cell-cycle regulation (1) |
Top2
|
none |
sp |
|
16496002
|
Mitosis |
Top2
|
Chromosome condensation defect |
np |
|
17412918
|
Microtubule assembly and organization |
Top2
|
Abnormal spindle, chromosome alignment defect, increased number of cells in prometaphase |
np |
|
18463163
|
Muscle morphogenesis and function (1) |
Top2
|
Lethal |
np |
|
20220848
|
Heat nociception (1) |
Top2
|
Developmentally lethal |
0.38 |
|
21074052
|
Heart development and function (1) |
Top2
|
none |
1 |
|
20371351
|
Serratia marcescens infection (1) |
Top2
|
Decreased viability after Serratia marcescens infection |
-3.71830985915492 |
|
19520911
|
Serratia marcescens infection (2) |
Top2
|
none |
sp |
|
19520911
|
Serratia marcescens infection (4) |
Top2
|
none |
sp |
|
19520911
|
Notch pathway regulation (4) |
Top2
|
Notum malformation death |
9 |
|
19363474
|
G2-M DNA damage checkpoint regulation (2) |
Top2
|
Increased histone H3 phosphorylation with doxorubicin |
102.24 |
with doxorubicin |
21205937
|
G2-M DNA damage checkpoint regulation (2) |
Top2
|
Increased histone H3 phosphorylation with etoposide |
95.33 |
with etoposide |
21205937
|
G2-M DNA damage checkpoint regulation (2) |
Top2
|
Increased histone H3 phosphorylation after X-ray exposure |
51.38 |
X-ray exposure |
21205937
|
G2-M DNA damage checkpoint regulation (2) |
Top2
|
Increased histone H3 phosphorylation with bleocin |
18.74 |
with bleocin |
21205937
|
Blood cell homeostasis regulation (1) |
Top2
|
none |
np |
|
20540764
|
Blood cell homeostasis regulation (2) |
Top2
|
none |
np |
|
20540764
|
RTK-Ras-ERK pathway regulation (1) |
Top2
|
none |
-0.37 |
10 minutes EGF stimulation |
22028469
|
RTK-Ras-ERK pathway regulation (1) |
Top2
|
none |
-0.96 |
0 minutes EGF stimulation |
22028469
|
RTK-Ras-ERK pathway regulation (2) |
Top2
|
none |
-0.06 |
30 minutes sSpitz stimulation |
22028469
|
RTK-Ras-ERK pathway regulation (2) |
Top2
|
none |
-1.01 |
10 minutes sSpitz stimulation |
22028469
|
Hippo pathway regulation |
Top2
|
none |
1.19 |
|
23263283
|
Glycosylation regulation (1) |
Top2
|
Increased alpha1,6-fucose Chp glycosylation |
sp |
|
21203496
|
Glycosylation regulation (2) |
Top2
|
none |
np |
|
21203496
|